• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Animal & Veterinary

  • Print
  • Share
  • E-mail

REGULATORY ACTIVITIES - January/February 1999

FDA Veterinarian Newsletter January/February 1999 Volume XIV, No I

The following firms/individuals received warning letters for offering animals for slaughter that contained illegal drug residues:

  • George McArthur, McArthur Livestock, McArthur, CA
  • Robert N. Hansen, 3H Cattle Company, Corcoran, CA
  • Randall P. Meabon, Greem Meadow Farm, Wattsburg, PA
  • Robert G. Gioletti, Robert Gioletti and Sons Dairy, Inc., Turlock, CA
  • Gerald W. Brouwer, Crestview Calf Ranch, Hanford, CA
  • Larry Freeborn, Tranquility Farms, Inc., Andover, NJ

These violations involved illegal residues of tilmicosin in cows, gentamicin and sulfamethazine in cows, streptomycin in a dairy cow, gentamicin sulfate in a bob veal calf, and gentamicin sulfate in a cow.

A warning letter was sent to Heduino V. Brasil, H&I Dairy, Tipton, CA, whose firm had a history of offering animals for sale for human food use which were adulterated with drug residues. This warning letter stated that his firm had consigned a dairy cow for slaughter that contained illegal residues of streptomycin.

James E. Thaxton, President of Georgia Turkey Farms, Inc., Watkinsville, GA, received a warning letter for violations from Good Manufacturing Practices (GMPs) for medicated feeds.

A warning letter was sent to Norman Smith, V.M.D., Shippenville, PA, for ordering gentamicin for treating animals without providing veterinary oversight for this use. The letter stated that Dr. Smith provided his clients with no directions for use or withholding time for slaughter for the drug. The clients used the gentamicin to treat a cow which they offered for slaughter. The cow contained illegal residues of gentamicin. While gentamicin is not approved for use in cattle, under certain circumstances a veterinarian may consider such extra-label use when the health of the animal is threatened and suffering or death would result from failure to treat the affected animal. However, such extra-label use must be by or on the order of a licensed veterinarian within the context of a valid veterinarian/client/patient relationship, and that use may not result in any residue which may present a risk to the public health.